Black J B, Schwarz T F, Patton J L, Kite-Powell K, Pellett P E, Wiersbitzky S, Bruns R, Müller C, Jäger G, Stewart J A
Division of Viral and Rickettsial Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA.
Clin Diagn Lab Immunol. 1996 Jan;3(1):79-83. doi: 10.1128/cdli.3.1.79-83.1996.
An enzyme immunoassay (EIA), an immunoblot assay (IB), and an indirect immunofluorescence assay were developed for detection of human herpesvirus 7 (HHV-7) antibodies in human serum. Cross-absorption studies with EIA or IFA using HHV-7 and human herpesvirus 6 (HHV-6) antigens indicated that most human sera contain cross-reactive HHV-6 and HHV-7 antibodies and that the degree of cross-reactivity varies between individual serum specimens. Inhibition of homologous antibody activity by absorption with heterologous virus ranged from 0 to 57% by EIA. However, for every sample tested, absorption with homologous virus removed more activity than did heterologous virus. An 89-kDa protein was identified as an HHV-7-specific serologic marker by IB. Activity to this protein was not removed by absorption with HHV-6 antigen. Of the three assays, the EIA was the most sensitive (94%), while the IB was the most specific (94%). Approximately 80% of specimens collected from German adults and children older than 2 years were positive for HHV-7 antibodies by these assays.
开发了一种酶免疫测定法(EIA)、一种免疫印迹测定法(IB)和一种间接免疫荧光测定法,用于检测人血清中的人疱疹病毒7(HHV-7)抗体。使用HHV-7和人疱疹病毒6(HHV-6)抗原进行的EIA或IFA交叉吸收研究表明,大多数人血清中含有交叉反应性的HHV-6和HHV-7抗体,并且交叉反应程度在各个血清样本之间有所不同。通过EIA,用异源病毒吸收对同源抗体活性的抑制范围为0%至57%。然而,对于每个测试样本,用同源病毒吸收比用异源病毒吸收去除的活性更多。通过IB鉴定出一种89 kDa的蛋白质作为HHV-7特异性血清学标志物。用HHV-6抗原吸收不会去除对该蛋白质的活性。在这三种测定法中,EIA最敏感(94%),而IB最特异(94%)。通过这些测定法,从德国成年人和2岁以上儿童采集的样本中约80%的HHV-7抗体呈阳性。